These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 27468715

  • 1. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B, Regazzo D, Redaelli M, Mucignat C, Citton M, Iacobone M, Scaroni C, Betterle C, Mantero F, Fassina A, Pezzani R, Boscaro M.
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [Abstract] [Full Text] [Related]

  • 2. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas.
    Pereira SS, Máximo V, Coelho R, Batista R, Soares P, Guerreiro SG, Sobrinho-Simões M, Monteiro MP, Pignatelli D.
    J Cell Biochem; 2017 Aug; 118(8):2064-2071. PubMed ID: 27886397
    [Abstract] [Full Text] [Related]

  • 3. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
    Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi CL.
    Oncotarget; 2017 Feb 07; 8(6):9323-9338. PubMed ID: 28030838
    [Abstract] [Full Text] [Related]

  • 4. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J.
    J Clin Endocrinol Metab; 2008 Oct 07; 93(10):4135-40. PubMed ID: 18647815
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.
    Cancer Res; 2005 Sep 01; 65(17):7622-7. PubMed ID: 16140927
    [Abstract] [Full Text] [Related]

  • 8. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC, Nicolson NG, Korah R, Carling T.
    J Am Coll Surg; 2018 Jun 01; 226(6):988-995. PubMed ID: 29428231
    [Abstract] [Full Text] [Related]

  • 9. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
    Ronchi CL, Sbiera S, Altieri B, Steinhauer S, Wild V, Bekteshi M, Kroiss M, Fassnacht M, Allolio B.
    Endocr Relat Cancer; 2015 Aug 01; 22(4):531-43. PubMed ID: 25979380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
    Parviainen H, Schrade A, Kiiveri S, Prunskaite-Hyyryläinen R, Haglund C, Vainio S, Wilson DB, Arola J, Heikinheimo M.
    Pathol Res Pract; 2013 Aug 01; 209(8):503-9. PubMed ID: 23866946
    [Abstract] [Full Text] [Related]

  • 15. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
    Papathomas TG, Duregon E, Korpershoek E, Restuccia DF, van Marion R, Cappellesso R, Sturm N, Rossi G, Coli A, Zucchini N, Stoop H, Oosterhuis W, Ventura L, Volante M, Fassina A, Dinjens WN, Papotti M, de Krijger RR.
    Hum Pathol; 2016 Dec 01; 58():113-122. PubMed ID: 27589897
    [Abstract] [Full Text] [Related]

  • 16. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
    Romero Arenas MA, Whitsett TG, Aronova A, Henderson SA, LoBello J, Habra MA, Grubbs EG, Lee JE, Sircar K, Zarnegar R, Scognamiglio T, Fahey TJ, Perrier ND, Demeure MJ.
    Ann Surg Oncol; 2018 Mar 01; 25(3):801-807. PubMed ID: 29218429
    [Abstract] [Full Text] [Related]

  • 17. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A, Min IM, Crowley MJP, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey TJ.
    Ann Surg Oncol; 2018 Mar 01; 25(3):792-800. PubMed ID: 29214451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.